CONTACT

ICD-10 Coding Clinic Update (Q3 2020): Long Term Use of GLP-1 Antagonist with Anti-diabetic drugs

Home / ICD-10 Coding Clinic Update (Q3 2020): Long Term Use of GLP-1 Antagonist with Anti-diabetic drugs

ICD-10 Coding Clinic Update (Q3 2020): Long Term Use of GLP-1 Antagonist with Anti-diabetic drugs

Hear Barry Libman, MS, RHIA, CDIP, CCS, a nationally-recognized authority on coding and reimbursement issues, discuss “ICD-10 Coding Clinic Update (Q3 2020): Long Term Use of GLP-1 Antagonist with Anti-diabetic drugs” in this free, brief presentation.

 

Listen to Barry’s Coding Clinic Commentary in its entirety. In-depth commentary on selected coding advice and clarifications from recent issues of AHA Coding Clinic — all from a nationally-recognized authority on coding and reimbursement issues! Learn more here.

About the Author

Barry Libman, MS, RHIA, CCS
Barry is the founder of Libman Education, a leading provider of training for the health care workforce, as well as Barry Libman Inc., a company that provides coding, audit, and educational services to the HIM departments of healthcare institutions. Prior to forming these organizations, he held a number of positions in the health information management field, working for hospitals, insurers, consulting firms, and regulatory bodies. Barry is recognized for his in-depth knowledge of coding and reimbursement issues for acute care hospitals. An area of particular interest and expertise is Long Term Acute Care Hospital (LTACH) coding. Barry is often called upon to provide education and training on code updates and coding issues.

Comments are closed.